SCHEMBL14992986

SCHEMBL14992986

CC(C)/[N+]([O-])=C\c1ccc(O)cc1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TYR P14679 4/20 0.41
SYNJ2 O15056 1/20 0.41
TTR P02766 1/20 0.41
CYP1A1 P04798 1/20 0.41
BCHE P06276 1/20 0.41
MMP2 P08253 1/20 0.41
ALOX5 P09917 1/20 0.41
PTPN1 P18031 1/20 0.41
PTGS1 P23219 1/20 0.41
CYP1B1 Q16678 1/20 0.41
PTPN22 Q9Y2R2 1/20 0.41
MAPT P10636 4/20 0.38
KDM4E B2RXH2 2/20 0.38
GAA P10253 2/20 0.38
ALDH1A1 P00352 1/20 0.38
MEN1 O00255 2/20 0.38
POLB P06746 2/20 0.38
KMT2A Q03164 2/20 0.38
CHRNA7 P36544 3/20 0.37
ALPL P05186 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14993714 1.00 TYR (0.41) TYRSYNJ2TTRCYP1A1BCHE
SCHEMBL14992989 1.00 TYR (0.41) TYRSYNJ2TTRCYP1A1BCHE
SCHEMBL19428620 0.80 TYR (0.42) TYRSYNJ2TTRCYP1A1BCHE
SCHEMBL14993292 0.78 TRIM24 (0.42) MAPTKDM4EGAAALDH1A1MEN1
SCHEMBL14993294 0.78 TRIM24 (0.42) MAPTKDM4EGAAALDH1A1MEN1
SCHEMBL14993291 0.78 TRIM24 (0.42) MAPTKDM4EGAAALDH1A1MEN1
SCHEMBL27536482 0.75 TYR (0.41) TYRSYNJ2TTRCYP1A1BCHE
SCHEMBL14993281 0.73 EGFR (0.42) MAPTKDM4EALDH1A1
SCHEMBL14993283 0.73 EGFR (0.42) MAPTKDM4EALDH1A1
SCHEMBL14993280 0.73 EGFR (0.42) MAPTKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180071186-A1 NITRONE INHIBITION OF OXIDATION OF UNSATURATED FATS ROHM AND HAAS COMPANY 2018-03-15 US claimed
US-20180055749-A1 NITRONE INHIBITION OF OXIDATION OF UNSATURATED FATS ROHM AND HAAS COMPANY 2018-03-01 US claimed
EP-3270875-A1 NITRONE INHIBITION OF OXIDATION OF UNSATURATED FATS Dow Global Technologies LLC (US) 2018-01-24 EP claimed
EP-3270876-A1 NITRONE INHIBITION OF OXIDATION OF UNSATURATED FATS Dow Global Technologies LLC (US) 2018-01-24 EP claimed
WO-2016154018-A9 NITRONE INHIBITION OF OXIDATION OF UNSATURATED FATS DOW GLOBAL TECHNOLOGIES LLC (US) 2017-10-05 WO claimed
WO-2016154018-A1 NITRONE INHIBITION OF OXIDATION OF UNSATURATED FATS DOW GLOBAL TECHNOLOGIES LLC (US) 2016-09-29 WO claimed
WO-2016154022-A1 NITRONE INHIBITION OF OXIDATION OF UNSATURATED FATS DOW GLOBAL TECHNOLOGIES LLC (US) 2016-09-29 WO claimed
US-20150335546-A1 NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE DOW GLOBAL TECHNOLOGIES LLC 2015-11-26 US claimed
US-20140303255-A1 NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE DOW GLOBAL TECHNOLOGIES LLC 2014-10-09 US claimed
EP-2785316-A2 NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE ANGUS Chemical Company (US) 2014-10-08 EP claimed
WO-2013081778-A2 NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE ANGUS CHEMICAL COMPANY (US) 2013-06-06 WO claimed
EP-3270876-B1 NITRONE INHIBITION OF OXIDATION OF UNSATURATED FATS DOW GLOBAL TECHNOLOGIES LLC (US) 2021-12-22 EP disclosed
EP-2785316-B1 NITRONE COMPOUNDS FOR USE AS ANTIOXIDANT IN PERSONAL CARE DOW GLOBAL TECHNOLOGIES LLC (US) 2019-06-19 EP disclosed
EP-3270875-B1 NITRONE INHIBITION OF OXIDATION OF UNSATURATED FATS DOW GLOBAL TECHNOLOGIES LLC (US) 2019-05-01 EP disclosed
US-10137071-B2 Nitrone inhibition of oxidation of unsaturated fats DOW GLOBAL TECHNOLOGIES LLC (US) 2018-11-27 US disclosed
US-9452118-B2 Nitrone compounds and their use in personal care DOW GLOBAL TECHNOLOGIES LLC (US) 2016-09-27 US disclosed
US-20150335546-A1 NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE DOW GLOBAL TECHNOLOGIES LLC 2015-11-26 US disclosed
US-20140303255-A1 NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE DOW GLOBAL TECHNOLOGIES LLC 2014-10-09 US disclosed
EP-2785316-A2 NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE ANGUS Chemical Company (US) 2014-10-08 EP disclosed
WO-2013081778-A2 NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE ANGUS CHEMICAL COMPANY (US) 2013-06-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140303255-A1 NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE NOX1, NOX5, NOS1 TYR 178/4885SYNJ2 4133/4885TTR 714/4885
US-10137071-B2 Nitrone inhibition of oxidation of unsaturated fats FASN, NDUFB1, FADS1 TYR 1505/4885SYNJ2 2408/4885TTR 3064/4885
US-20150335546-A1 NITRONE COMPOUNDS AND THEIR USE IN PERSONAL CARE NOX1, NOX5, NOS1 TYR 178/4885SYNJ2 4133/4885TTR 714/4885
US-20180055749-A1 NITRONE INHIBITION OF OXIDATION OF UNSATURATED FATS FASN, NDUFB1, FADS1 TYR 1505/4885SYNJ2 2408/4885TTR 3064/4885
US-20180071186-A1 NITRONE INHIBITION OF OXIDATION OF UNSATURATED FATS FASN, TXNRD2, NOS1 TYR 1786/4885SYNJ2 2537/4885TTR 3226/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.